ArticleFrontiers in pharmacology2022

Proteomic Analysis of Potential Targets for Non-Response to Infliximab in Patients With Ulcerative Colitis.

Lu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.